Red Cat Holdings, Inc. (RCAT) Q4 2025 Earnings Results
Earnings Per Share (GAAP) $-0.17 vs $-0.15 est. Revenue $26.2M vs $23.9M est. Loss widens beyond expectations. Red Cat Holdings ...
Earnings Per Share (GAAP) $-0.17 vs $-0.15 est. Revenue $26.2M vs $23.9M est. Loss widens beyond expectations. Red Cat Holdings ...
Loss Per Share (GAAP) $0.26 Loss narrows sharply. Dogwood Therapeutics, Inc. (NASDAQ: DWTX) reported a loss of $0.26 per share ...
Earnings Per Share (GAAP) $-0.44 estimate N/A Revenue $254.0M estimate N/A Analyst sentiment holds steady. The consensus rating distribution remains ...
Earnings Per Share (GAAP) $0.01 estimate N/A Revenue $19.3M estimate N/A Analyst skepticism persists. The consensus rating distribution shows five ...
The J. M. Smucker Company (NYSE:SJM) is included among the 13 Undervalued Dividend Aristocrats to Buy Now. The J. M. ...
“ Verrica narrows Q4 loss 72% year-over-year to -$0.51 per share as revenue surges 1,383% to $5.1M, though sequential revenue ...
Loss Per Share $-1.43 vs $-1.03 est. Loss widens sharply. Dianthus Therapeutics, Inc. (DNTH) reported a loss of $1.43 per ...
Earnings Per Share (GAAP) $-0.58 estimate N/A Revenue $17.3M estimate N/A Loss narrows sequentially. Boundless Bio Inc reported a loss ...
Revenue was driven primarily by: Investment banking and new issue activity: $54.7 million Principal transactions and other revenue: $31.5 million ...
Revenue: $1.43 billion, up 33% year over year. Revenue exceeded analyst expectations of about $1.40 billion. The strong growth was ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.